Oestrogen deficiency in men: Where are we today?

European Journal of Endocrinology

Volumn 140, Issue 2, 1999, Pages 111-129

  Faustini Fustini, Marco ^a   Rochira, Vincenzo ^a   Carani, Cesare ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LUTEINIZING HORMONE; OSTEOCALCIN; PRASTERONE; PROLACTIN; SOMATOMEDIN C; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL TISSUE; BONE AGE; BONE MINERALIZATION; ESTROGEN DEFICIENCY; GENE DISRUPTION; GENOTYPE; GLUCOSE BLOOD LEVEL; GONAD FUNCTION; HISTOPATHOLOGY; HORMONAL REGULATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ERRATUM; ERROR;

AROMATASE; BONE DEVELOPMENT; CARDIOVASCULAR DISEASES; DRUG RESISTANCE; ESTROGENS; GENITALIA, MALE; HUMANS; INSULIN RESISTANCE; MALE; MUTATION; RECEPTORS, ESTROGEN; SEX CHARACTERISTICS;

EID: 0033061324     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400111     Document Type: Review

References (155)

1. George FW & Wilson JD. Sex determination and differentiation. In The Physiology of Reproduction, ch 1, pp 3-26. Eds E Knobil & JD Neill. New York: Raven Press, 1988.
2. Quigley CA, De Bellis A, Marschke, KB, El-Awady MK, Wilson EM & French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 1995 16 271-321.
3. Refetoff S, Weiss RE & Usala SJ. The syndrome of resistance to thyroid hormone. Endocrine Reviews 1993 14 348-399.
4. Chatterjee VKK & Beck-Peccoz P. Thyroid hormone resistance. Bailliere's Clinical Endocrinology and Metabolism 1994 8 267-283.
5. Chrousos GP, Detera-Wadleigh S & Karl M. Syndromes of glucocorticoid resistance. Annals of Internal Medicine 1993 119 1198-1208.
6. Shozu M, Akasofu K, Harada T & Rubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. Journal of Clinical Endocrinology and Metabolism 1991 72 560-566.
7. Harada N, Ogawa H, Shozu M, Yamada K, Suhara K, Nishida E et al. Biochemical and molecular genetic analyses on placental aromatase (P-450 arom) deficiency. Journal of Biological Chemistry 1992 267 4781-4785.
8. Harada N, Ogawa H, Shozu M & Yamada K. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. American Journal of Human Genetics 1992 51 666-672.
9. Ito Y, Fisher CR, Conte FA, Grumbach MM & Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proceedings of the National Academy of Sciences of the USA 1993 90 11673-11677.
10. Conte FA, Grumbach MM, Ito Y, Fisher CR & Simpson ER. A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). Journal of Clinical Endocrinology and Metabolism 1994 78 1287-1292.
11. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994 331 1056-1061.
12. Lubahn DB, Mojer JS, Golding TS, Couse JF, Korach KS & Smities O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proceedings of the National Academy of Sciences of the USA 1993 90 11162-11166.
13. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994 266 1524-1527.
14. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 3689-3698.
15. Portrat-Doyen S, Forest MG, Nicolino M, Morel Y & Chatelain PC. Female pseudohermaphroditism resulting from aromatase (P450arom) deficiency associated with a novel mutation (R457X) in the CYP19 gene. Hormone Research 1996 46 (Suppl 2) 14.
16. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P & Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism. multicystic ovaries, and bone densitometry in childhood. Journal of Clinical Endocrinology and Metabolism 1997 82 1739-1745.
17. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J et al. Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 1997 337 91-95.
18. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. The nuclear receptor superfamily: the second decade. Cell 1995 83 835-839.
19. Ciocca DR & Vargas Roig LM. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Reviews 1995 16 35-62.
20. Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A & Watson PH. Estrogen receptor variants and mutations. Journal of Steroid Biochemistry and Molecular Biology 1997 62 365-372.
21. Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakdel F, Reese JC et al. Hormone binding and transcription activation by estrogen receptors analyses using mammalian and yeast systems, Journal of Steroid Biochemistry and Molecular Biology 1993 47 39-48.
22. Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biology of Reproduction 1996 54 287-293.
23. Ekena KE, Weis KE, Katzenellenbogen JA & Katzenellenbogen BS. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. Journal of Biological Chemistry 1996 271 20053-20059.
24. Bocchinfuso WP & Korach KS. Estrogen receptor residues required for stereospecific ligand recognition and activation. Molecular Endocrinology 1997 11 587-594.
25. Ignar-Trowbricge DM, Teng CT, Ross KA, Purker MG, Korach KS & McLachlan JA. Peptide growth factors elicit estrogen receptor-dependent trar scriptional activation of an estrogen-responsive element. Molecular Endocrinology 1993 7 992-998.
26. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF et al Physiological coupling of growth factor and steroid receptor signaling pathway: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proceedings of the National Academy of Sciences of the USA 1996 93 12626-12630.
27. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the USA 1996 93 5925-5930.
28. Mosselman S, Polman J & Dijkema R. ER-β: identification and characterization of a novel human estrogen receptor FEBS Letters 1996 392 49-53.
29. Kuiper GGJM, Carlsson B, Grandien J, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997 138 863-870.
30. Cowley SM, Hoare S, Mosselman S & Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. Journal of Biological Chemistry 1997 272 19858-19862.
31. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews 1994 15 342-355.
32. Means GD, Mahendroo M, Corbin CJ, Mathis JM, Powell FE, Mendelson CR et al. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. Journal of Biological Chemistry 1989 264 19385-19391.
33. Harada N, Yamada K, Saito K, Kibe N, Dohmae S & Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene. Biochemical and Biophysical Research Communications 1990 166 365-372.
34. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR & Simpson ER. Isolation of a full length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in non-steroidogenic cells. Proceedings of the National Academy of Sciences of the USA 1988 85 8948-8952.
35. McNatty KP, Makris A & DeGrazia C. The production of progesterone, androgens, and estrogens by granulosa cells, theca tissue and stromal tissue from human ovaries in vitro. Journal of Clinical Endocrinology and Metabolism 1979 49 687-699.
36. Bulun SE, Rosenthal IM, Brodie AMH, Inkster SE, Zeller WP, DiGeorge AM et al. Use of tissue specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumours, as well as in normal fetal and adult gonads. Journal of Clinical Endocrinology and Metabolism 1993 77 1616-1621.
37. Inkster SE & Brodie AMH. Expression of aromatase P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. Journal of Clinical Endocrinology and Metabolism 1991 73 717-726.
38. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR & Simpson ER. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinology 1991 5 2005-2013.
39. Kellis JT & Vickery LE. Purification and characterization of human placental aromatase cytochrome P-450. Journal of Biological Chemistry 1987 262 4413-4420.
40. Fournet-Dulguerov N, MacLusky NJ, Leranth CZ, Todd R, Mendelson CR, Simpson ER et al. Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta. Journal of Clinical Endocrinology and Metabolism 1987 65 757-764.
41. Inkster SE & Brodie AMH. Immunocytochemical studies of aromatase in early and full-term human placental tissue: comparison with biochemical assays. Biology of Reproduction 1989 41 889-898.
42. Kilgore MW, Means GD, Mendelson CR & Simpson ER. Alternative promotion of aromatase cytochrome P450 expression in human fetal tissues. Molecular and Cellular Endocrinology 1992 83 R9-R16.
43. Kelch RP, Jenner MR, Weinstein R, Kaplan SL & Grumbach MM. Estradiol and testosterone secretion by human, simian and canine testes, in male with hypogonadism and in male pseudohermaphrodite with the feminizing testes syndrome. Journal of Clinical Investigation 1972 51 824-830.
44. Payne AH, Kelch RP, Musich S & Halpern ME. Intratesticular site of aromatization in the human. Journal of Clinical Endocrinology and Metabolism 1976 42 1081-1087.
45. Tsai-Morris C-H, Aquilano DR & Dufau ML. Cellular localization of rat testicular aromatase activity during development. Endocrinology 1985 116 38-46.
46. Brodie A & Inkster S. Aromatase in the human testis. Journal of Steroid Biochemistry and Molecular Biology 1993 44 549-555.
47. Elias AN, Valenta LJ & Domurat ES. Male hypogonadism due to nontumorous hyperestrogenism. Journal of Andrology 1990 11 485-490.
48. Valenta LJ. Human testicular aromatase: clinical experience. Journal of Clinical Endocrinology and Metabolism 1995 80 3098-3099.
49. Inkster S, Yue W & Brodie A. Human testicular aromatase: immunocytochemical and biochemical studies. Journal of Clinical Endocrinology and Metabolism 1995 80 1941-1947.
50. Nitta H, Bunick D, Hess RA, Janulis L, Newton SC, Millette CF et al. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993 132 1396-1401.
51. Janulis L, Hess RA, Bunick D, Nitta H, Janssen S, Asawa Y et al. Mouse epididymal sperm contain active P450 aromatase which decreases as sperm traverse the epididymis. Journal of Andrology 1996 17 111-116.
52. Kwon S, Hess RA, Bunick D, Nitta H, Janulis L, Osawa Y et al. Rooster testicular germ cells and epididymal sperm contain P450 aromatase. Biology of Reproduction 1995 53 1259-1264.
53. Almadhidi J, Seralini G-E, Fresnel J, Silberzahn P & Gaillard J-L. Immunohistochemical localization of cytochrome P450 aromatase in equine gonads. Journal of Histochemistry and Cytochemistry 1995 43 571-577.
54. Nakazumi H, Sasano H, Maehara I, Ozaki M, Tezuka F & Orikasa S. Estrogen metabolism and impaired spermatogenesis in germ cell tumours of the testis. Journal of Clinical Endocrinology and Metabolism 1996 81 1289-1295.
55. Longcope C, Pratt JH, Schneider SH & Fineberg SE. Aromatization of androgens by muscle and adipose tissue in vitro. Journal of Clinical Endocrinology and Metabolism 1978 46 146-152.
56. Mendelson CR, Cleland WH, Smith ME & Simpson ER. Regulation of aromatase activity of stromal cells derived from human adipose tissue Endocrinology 1982 111 1077-1085.
57. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S & Mendelson CR. Regulation of estrogen biosynthesis by human adipose cells. Endocrine Reviews 1989 10 136-148.
58. Mahendroo MS, Means GD, Mendelson CR & Simpson ER. Tissue-specific expression of human P450 arom: the promoter responsible for expression in adipose is different from that utilized in placenta. Journal of Biological Chemistry 1991 266 11276-11281.
59. Mahendroo MS, Mendelson CR & Simpson ER. Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. Journal of Biological Chemistry 1993 268 19463-19470.
60. Zhao Y, Mendelson CR & Simpson ER. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Molecular Endocrinology 1995 9 340-349.
61. Zhao Y, Nichols JE, Bulun SE, Mendelson CR & Simpson ER. Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter. Journal of Biological Chemistry 1995 270 16449-16457.
62. Agarwal VR, Ashanullah CI, Simpson ER & Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. Journal of Clinical Endocrinology and Metabolism 1997 82 70-74.
63. Siiteri PK & Seron-Ferre M. Secretion and metabolism of adrenal androgens to estrogens. In The Endocrine Function of the Human Adrenal Cortex, pp 251-264. Eds VHT James, M Serio, G Giusti & L Martini, New York: Academic Press, 1978.
64. Roselli CE, Hurton LE & Resko JA. Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 1985 117 2471-2477.
65. Beyer C, Green SJ & Hutchison JB. Androgens influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro. Endocrinology 1994 135 1220-1226.
66. Lauber ME & Lichtensteiger W. Pre- and postnatal ontogeny of aromatase cytochrome P450 messenger ribonucleic acid expression in the male rat brain studied by in situ hybridization. Endocrinology 1994 135 1661-1666.
67. Lephart ED. A review of brain aromatase cytochrome P450. Brain Research Reviews 1996 22 1-26.
68. Hutchison JB, Wozniak A, Beyer C & Hutchison RE. Regulation of sex-specific formation of oestrogen in brain development: endogenous inhibitors of aromatase. Journal of Steroid Biochemistry and Molecular Biology 1996 56 201-207.
69. Schweikert HU, Milewich L & Wilson JD. Aromatization of androstenedione by isolated human hairs. Journal of Clinical Endocrinology and Metabolism 1975 40 413-417.
70. Berkovitz GD, Bisat T & Carter KM. Aromatase activity in microsomal preparations of human genital skin fibroblasts: influence of glucocorticoids. Journal of Steroid Biochemistry 1989 33 341-347.
71. Harada N. A unique aromatase (P450 arom) mRNA formed by alternative use of tissue specific exons I in human skin fibroblasts. Biochemical and Biophysical Research Communications 1992 189 1001-1007.
72. Price T, Aitken J & Simpson ER. Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction (PCR) amplification. Journal of Clinical Endocrinology and Metabolism 1992 74 879-883.
73. Harada N, Utsume T & Takagi Y. Tissue-specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proceedings of the National Academy of Sciences of the USA 1993 90 11312-11316.
74. Toda K, Simpson ER, Mendelson CR, Shizuta Y & Kilgore MW. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Molecular Endocrinology 1994 8 210-217.
75. Noble LS, Simpson ER, Johns A & Bulun SE. Aromatase expression in endometriosis. Journal of Clinical Endocrinology and Metabolism 1996 81 174-179.
76. Bulun SE, Economos K, Miller D & Simpson ER. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumours. Journal of Clinical Endocrinology and Metabolism 1994 79 1831-1834.
77. Miller WR & O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 1987 50 537-548.
78. Bulun SE & Simpson ER. Regulation of the CYP19 (P450 arom) gene expression in breast adipose tissue and breast cancer. Trends in Endocrinology and Metabolism 1994 5 113-120.
79. Sasano H, Nagura H, Harada N, Goukon Y & Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human Pathology 1994 25 530-535.
80. Bulun SE, Sharda G, Rink J, Sharma S & Simpson ER. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. Journal of Clinical Endocrinology and Metabolism 1996 81 1273-1277.
81. Dowsett M, Lee K, Macaulay VM, Detre S, Rowlands M & Grimshaw R. The control and biological importance of intratumoral aromatase in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 1996 56 145-150.
82. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ et al. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 1996 137 3061-3068.
83. Santner SJ, Pauley RJ, Tait L, Kaseta J & Santen RJ. Aromatase activity and expression in breast cancer and benign tissue stromal cells. Journal of Clinical Endocrinology and Metabolism 1997 82 200-208.
84. O'Marcaigh AS, Ledger GA, Roche PC, Parisi JE & Zimmerman D. Aromatase expression in human germinomas with possible biological effects. Journal of Clinical Endocrinology and Metabolism 1995 80 3763-3766.
85. Young JY, Bulun SE, Agarwal V, Couzinet B, Mendelson CR, Simpson ER et al. Aromatase expression in a feminizing adrenocortical tumor. Journal of Clinical Endocrinology and Metabolism 1996 81 3173-3176.
86. Toda K, Nomoto S & Shizuta Y. Identification and characterization of transcriptional regulatory elements of the human aromatase cytochrome P450 gene (CYP19). Journal of Steroid Biochemistry and Molecular Biology 1996 56 151-159.
87. Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE & Zhao Y. Expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB Journal 1997 11 29-36.
88. Shozu M, Zhao Y, Bulun SE & Simpson E. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6. Endocrinology 1998 139 1610-1617.
89. Lindzey J & Korach KS. Developmental and physiological effects of estrogen receptor gene disruption in mice. Trends in Endocrinology and Metabolism 1997 8 137-145.
90. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Molecular Endocrinology 1995 9 1441-1454.
91. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996 137 4796-4805.
92. Hess RA, Bunick D, Lee K-H, Bahr J, Taylor JA, Korach KS et al. A role for oestrogens in the male reproductive system. Nature 1997 390 509-512.
93. Ogawa S, Lubahn DB, Korach KS & Pfaff DW. Behavioral effects of estrogen receptor gene disruption in male mice, Proceedings of the National Academy of Sciences of the USA 1997 94 1476-1481.
94. Rissman EF, Wersinger SR, Taylor JA & Lubahn DB. Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Hormones and Behaviour 1997 31 232-243.
95. Wersinger SR, Sannen K, Villalba C, Lubahn DB, Rissman EF & De-Vries GJ. Masculine sexual behaviour is disrupted in male and female mice lacking a functional estrogen receptor alpha gene. Hormones and Behaviour 1997 32 176-183.
96. Hou Q & Gorski J. Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proceedings of the National Academy of Sciences of the USA 1993 90 9460-9464.
97. Mango D, Montemurro A, Scirpa P, Bompiani A & Menini E. Four cases of pregnancy with low estrogen production due to placental enzymatic deficiency. European Journal of Obstetrics, Gynaecology and Reproductive Biology 1978 8 65-71.
98. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997 96 3774-3777.
99. Revelli A, Massobrio M & Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocrine Reviews 1998 19 3-17.
100. Sharpe RM & Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993 341 1392-1395.
101. Das SK, Taylor JA, Korach KS, Paria BC, Dey SK & Lubahn DB. Estrogenic responses in estrogen receptor-α deficient mice reveal a distinct estrcgen signaling pathway. Proceedings of the National Academy of Sciences of the USA 1997 94 12786-12791.
102. Conley A, Corbin J, Smith T, Hinshelwood M, Liu Z & Simpson E. Porcine aromatases: studies on tissue-specific, functionally distinct isozymes from a single gene? Journal of Steroid Biochemistry and Molecular Biology 1997 61 407-413.
103. Tchoudakova A & Callard GV. Identification of multiple CYP19 genes encoding different cytochrome P450 aromatase isozymes in brain and ovary. Endocrinology 1998 139 2179-2189.
104. Graham-Lorence S, Amarneh B, White RE, Peterson JA & Simpson ER. A three dimensional model of aromatase cytochrome P450. Protein Sciences 1995 4 1065-1080.
105. Chen S & Zhou D. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. Journal of Biological Chemistry 1992 267 22587-22594.
106. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988 241 84-87.
107. Davis VL, Couse JF, Gray TK & Korach KS. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. Journal of Bone and Mineral Research 1994 9 983-991.
108. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 1996 51 159-188.
109. Kimbro KS, Taki M, Beamer WG & Korach KS. Ovariectomized female estrogen receptor-α knockout and wild type mice respond differently to estrogen and dihydrotestosterone treatment. Annual Meeting of the Endocrine Society (ENDO'98) New Orleans, 1998, OR7-4, p 61 (Abstract).
110. Bogin B. Adolescence in evolutionary perspective. Acta Paediatrica (Suppl) 1994 406 29-35.
111. Cutler GB, Cassorla FG, Ross JL, Pescovitz OH, Barnes KM, Comite F et al. Pubertal growth: physiology and pathophysiology. Recent Progress in Hormone Research 1986 42 443-470.
112. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT & Baylink DJ. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989 124 1576-1578.
113. Pescovitz OH. The endocrinology of the pubertal growth spurt. Acta Paediatrica Scandinavica 1990 367 119-125.
114. Ritzen EM. Pubertal growth in genetic disorders of sex hormone action and secretion. Acta Paediatrica Scandinavica 1992 383 22-25.
115. Preece MA, Pan H & Ratcliffe SG. Auxological aspects of male and female puberty. Acta Paediatrica Scandinavica 1992 383 11-13.
116. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M & Smith ER. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. Journal of Clinical Endocrinology and Metabolism 1993 76 996-1001.
117. Metzger DL & Kerrigan JR. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. Journal of Clinical Endocrinology and Metabolism 1994 79 513-518.
118. Saggese G, Cesaretti G, Barsanti S & Rossi A. Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls. Journal of Pediatrics 1995 126 468-473.
119. Frank GR. The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton. Acta Paediatrica 1995 84 627-630.
120. Smith EP & Korach KS. Oestrogen receptor deficiency: consequences for growth. Acta Paediatrica (Suppl) 1996 417 39-43.
121. Lee PA & Witchel SF. The influence of estrogen on growth. Current Opinion in Pediatrics 1997 9 431-436.
122. Ohlsson C, Bengtsson B-A, Isaksson OGP, Andreassen TT & Slootweg MC. Growth hormone and bone. Endocrine Reviews 1998 19 55-79.
123. Zachmann M, Prader A, Sabel EH, Crigler JF, Ritzen EM, Atares M et al. Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls. Journal of Pediatrics 1986 108 694-697.
124. Yanase T, Simpson ER & Waterman MR. 17α-hydroxylase/ 17.20-lyase deficiency: from clinical Investigation to molecular definition. Endocrine Reviews 1991 12 91-108.
125. Bilezikian JP, Morishima A, Bell J & Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. New England Journal of Medicine 1998 339 599-603.
126. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI & Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Annals of Internal Medicine 1987 106 354-361.
127. Finkelstein JS, Klibanski A & Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty, Journal of Clinical Endocrinology and Metabolism 1996 81 1152-1155.
128. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T & Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993 365 652-654.
129. Iiri T, Herzmark P, Nakamoto JM, Van Dop C & Bourne HR. Rapid GDP release from Gsα in patients with gain and loss of endocrine function. Nature 1994 371 164-168.
130. Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL et al. Treatment of familial male precocious puberty with spironolactone and testolactone. New England Journal of Medicine 1989 320 496-502.
131. Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC & Brook CGD. The effect of oxandrolone on the growth hormone axes of boys with constitutional delay of growth and puberty. Clinical Endocrinology 1993 38 393-398.
132. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M & Smith ER. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. Journal of Clinical Endocrinology and Metabolism 1993 76 996-1001.
133. Finkelstein JS, Whitcomb RW, O'Dea LS, Longcope C, Schoenfeld DA & Crowley WF Jr. Sex steroid control of gonadotropin secretion in the human male. I. Effect of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. Journal of Clinical Endocrinology and Metabolism 1991 73 609-620.
134. Bagatell CJ, Dahl KD & Bremner WJ. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. Journal of Andrology 1994 15 15-21.
135. Hess RA, Gist DH, Bunick D, Lubahn DB, Farrell A, Bahr J et al. Estrogen receptor (α and β) expression in the excurrent ducts of the adult male rat reproductive tract. Journal of Andrology 1997 18 602-611.
136. Sharpe RM. Do males rely on female hormones? Nature 1997 390 447-448.
137. Fisher JS, Millar MR, Majdic G, Saunders PTK, Fraser HM & Sharpe RM. Immunolocalisation of oestrogen receptor-α within the testis and excurrent ducts of the rat and marmoset monkey from perinatal life to adulthood. Journal of Endocrinology 1997 153 485-495.
138. Saunders PTK, Maguire SM, Gaughan J & Millar RM. Expression of oestrogen receptor beta (ERβ) in multiple rat tissues visualised by immunohistochemistry. Journal of Endocrinology 1997 154 R13-R16.
139. Fisher CR, Graves KH, Parlow AF & Simpson ER, Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences of the USA 1998 95 6965-6970.
140. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P & Melis GB. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1992 74 1396-1400.
141. 2 cholesterol levels in normal men. Journal of Clinical Endocrinology and Metabolism 1994 78 855-861.
142. Pacchioni D, Papotti M, Andorno E, Bonino F, Mondardini A, Olivieri F et al. Expression of estrogen receptor mRNA in tumorous and non-tumorous liver tissue as detected by in situ hybridization. Journal of Surgical Oncology 1993 3 (Suppl) 14-17.
143. 2 cholesterol. Metabolism 1994 43 935-939.
144. Sudhir K, Chou TM, Messina LM, Hutchinson SJ, Korach KS, Chatterjee K et al. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 1997 349 1146-1147.
145. Eckardstein A, Kliesch S, Nieschlag E, Chirazi A, Assmann G & Behre HM. Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein (a). Journal of Clinical Endocrinology and Metabolism 1997 82 3367-3372.
146. Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. British Medical Journal 1996 312 473-478.
147. Jacobs DR, Mebane IL, Bangdwala SI, Criqui MH & Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the lipid research clinics prevalence study. American Journal of Epidemiology 1990 131 32-47.
148. Komesaroff PA, Black CVS & Westerman RA. A novel, nongenomic action of estrogen on the cardiovascular system. Journal of Clinical Endocrinology and Metabolism 1998 83 2313-2316.
149. Lindner V, Fingerle J & Reidy MA. Mouse model of artery injury. Circulation Research 1993 73 792-796.
150. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Medicine 1997 3 545-548.
151. Klein KO, Baron J, Colli MJ, McDonnell DP & Cutler GB. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. Journal of Clinical Investigation 1994 94 2475-2480.
152. Bulun SE. Aromatase deficiency in women and men: would you have predicted the phenotypes? Journal of Clinical Endocrinology and Metabolism 1996 81 867-871.
153. Asteria C. Importance of estrogens in human males' fertility and bone pathophysiology. European Journal of Endocrinology 1997 137 120-121.
154. Pilgrim C & Reisert J. Differences between male and female brains - developmental mechanisms and implications. Hormone and Metabolic Research 1992 24 151-159.
155. Hutchinson JB. Hormonal control of behaviour: steroid action in the brain. Current Opinions in Neurobiology 1991 1 562-570.